Biogen Blinks, Cedes Icahn 1 Board Seat

"No, no. Don't say that," he said. "Don't say that."

Icahn went on to criticize Biogen's current management again, calling it "dysfunctional."

The biotech concern held its annual meeting in Cambridge, Mass., Wednesday when the company's chairman suddenly gavelled a recess to the proceedings, extending the time shareholders have to vote for three hours. Icahn associates were heard yelling their protests from the floor.

When the meeting reconvened, company executives immediately adjourned it again without totting up the votes.

Icahn immediately cried foul, accusing the company of manipulating the election, a charge that Biogen has denied.

Biogen shares closed Thursday at $53.15, down 28 cents for the day.